Description
RA-223 XOFIGO THERAPEUTIC RADIOPHARMACUETICAL FOR THE RELIEF OF BONE PAIN AND FRACTURE CAUSED BY PROSTATE CANCER.
Base award description: XOFIGO
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2019-10-01+$342,075= $342,075
- Mod P000012021-07-28-$173,648= $168,427
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2019-10-01 | +$342,075 | $342,075 | XOFIGO |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2021-07-28 | −$173,648 | $168,427 | RA-223 XOFIGO THERAPEUTIC RADIOPHARMACUETICAL FOR THE RELIEF OF BONE PAIN AND FRACTURE CAUSED BY PROSTATE CANC… |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI V1EVGCK7XES8)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25626N0492 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6505 · DRUGS AND BIOLOGICALS | $386,860 | FY2026 |
| 36C26226F0163 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $181,386 | FY2026 |
| 36C26026F0086 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $80,663 | FY2026 |
| 36C26126N0199 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $101,567 | FY2026 |
| 36C25626N0126 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6505 · DRUGS AND BIOLOGICALS | $214,783 | FY2026 |
| 36E79725A0028 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2025 |
Other recipients under 6505 from 262-NETWORK CONTRACT OFFICE 22 (36C262) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26226N0873 | CENTRAL ADMIXTURE PHARMACY SERVICES, INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $140,823 | FY2026 |
| 36C26226N0871 | CENTRAL ADMIXTURE PHARMACY SERVICES, INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $231,746 | FY2026 |
| 36C26226N0870 | CENTRAL ADMIXTURE PHARMACY SERVICES, INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $167,369 | FY2026 |
| 36C26226N0872 | CENTRAL ADMIXTURE PHARMACY SERVICES, INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $164,265 | FY2026 |
| 36C26226P1412 | ASD SPECIALTY HEALTHCARE, LLC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $38,220 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26220F0013_3600_V797P2202D_3600 · retrieved 2026-09-26.